Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce

    2026-04-22

    Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Cells: Dissecting Endocytic Pathways and Cellular Responses

    Study Background and Research Question

    Spiroplasma eriocheiris is an atypical, wall-less prokaryote that has emerged as a significant pathogen in crustacean aquaculture, causing economic losses and posing a threat to diverse hosts including both invertebrates and vertebrates (Wei et al., 2019). Despite its impact, the cellular mechanisms underlying host cell invasion have remained unresolved, largely due to the absence of established crustacean cell lines and the use of distantly related mammalian models. To address this gap, Wei and colleagues utilized the Drosophila Schneider 2 (S2) cell line, which shares key features with crustacean cells and is widely adopted for modeling invertebrate-pathogen interactions. Their central question: By what cellular mechanisms does S. eriocheiris enter, survive, and propagate within S2 cells?

    Key Innovation from the Reference Study

    This study is the first to establish a robust S. eriocheiris-infected Drosophila S2 cell model, directly visualizing the pathogen’s entry and intracellular behavior. Critically, it elucidates that S. eriocheiris utilizes clathrin-mediated endocytosis and macropinocytosis for cell entry—contrasting with caveola-mediated pathways. Through the use of specific chemical inhibitors and cytoskeletal disruptors, the authors provide clear mechanistic dissection of entry routes, and reveal the cellular consequences including apoptosis, necrosis, and formation of inclusion bodies (Wei et al., 2019).

    Methods and Experimental Design Insights

    The research employed a combination of infection assays, cytochemical staining, fluorescence microscopy, and quantitative PCR to track S. eriocheiris invasion and replication. Key features of the experimental design include:

    • Inoculation of Drosophila S2 cells with S. eriocheiris and temporal tracking of intracellular bacterial copy number.
    • Assessment of cell viability, apoptosis, and necrosis using standard cytotoxicity assays and detection of reactive oxygen species (ROS).
    • Use of pharmacological inhibitors to dissect endocytic pathways: chlorpromazine and dynasore for clathrin-mediated endocytosis; EIPA and amiloride for macropinocytosis; methyl-β-cyclodextrin and nystatin for caveolae/cholesterol-dependent processes.
    • Application of nocodazole and cytochalasin B to perturb microtubules and actin filaments, respectively, evaluating effects on bacterial entry (Wei et al., 2019).

    Protocol Parameters

    • cell infection assay | S. eriocheiris MOI and time course (0–24 h) | S2 cell invasion studies | Time-resolved tracking of bacterial replication | paper
    • endocytosis inhibition | chlorpromazine (10 μg/mL) and dynasore (80 μM) | Inhibition of clathrin-mediated entry | Quantitative reduction in bacterial internalization | paper
    • macropinocytosis inhibition | EIPA (25 μM) | Blockade of macropinocytosis | Diminished intracellular S. eriocheiris | paper
    • cytoskeleton disruption | nocodazole (10 μM), cytochalasin B (5 μM) | Disruption of microtubules/actin | Strongly reduces bacterial entry | paper
    • apoptosis/necrosis quantification | Annexin V/PI staining, ROS detection | S2 cell fate assessment post-infection | Links infection to cell death modalities | paper

    Core Findings and Why They Matter

    1. S. eriocheiris Induces S2 Cell Apoptosis, Necrosis, and ROS Production: Infected S2 cells display marked loss of viability, increased apoptotic and necrotic markers, and heightened ROS generation. This parallels findings in mammalian and other invertebrate models, supporting the role of oxidative stress and cell death in pathogenesis (Wei et al., 2019).

    2. Entry via Clathrin-Mediated Endocytosis and Macropinocytosis: Use of specific inhibitors sharply reduced intracellular S. eriocheiris, confirming that uptake is dependent on clathrin-coated vesicles and macropinocytic processes. Cholesterol/caveolae disruption had no significant effect, excluding those pathways. This mechanistic clarity distinguishes S. eriocheiris from certain viruses and bacteria that exploit caveolar entry (Wei et al., 2019).

    3. Cytoskeletal Dependence: Both actin and microtubule integrity are essential for efficient bacterial invasion, as shown by substantial reduction in infection when disrupted. This positions the cytoskeleton as a potential target for modulating host susceptibility (Wei et al., 2019).

    4. Formation of Inclusion Bodies and Vacuoles: Rapid proliferation of S. eriocheiris leads to distinctive intracellular inclusion bodies and vacuolization, ultimately causing cell rupture and pathogen spread. This phenotype resembles infection dynamics in other non-mammalian models.

    Comparison with Existing Internal Articles

    Several internal resources contextualize these findings within broader research on endocytic entry and inhibitor application. For example, the article on grass carp reovirus details how clathrin-mediated endocytosis can be dissected using small-molecule inhibitors, including Rottlerin (Wang et al., 2018), paralleling the approach in the S. eriocheiris study. Moreover, articles such as “Rottlerin: Selective PKCδ Inhibitor for Cell Proliferation Inhibition” and “Rottlerin as a Translational Catalyst” explore the utility of PKC inhibitors in modulating apoptosis and cell signaling. The S. eriocheiris study, while not directly using Rottlerin, demonstrates the research value of targeted chemical inhibition for mechanistic dissection, as well as the importance of apoptosis induction and cytoskeletal dynamics—domains where Rottlerin has been frequently applied.

    Limitations and Transferability

    The use of Drosophila S2 cells, while more reflective of invertebrate host biology than mammalian lines, still does not fully recapitulate crustacean physiology. Absence of in vivo validation in crustacean hosts limits direct translational conclusions. Furthermore, inhibitor specificity can be variable; off-target effects of pharmacological agents must be considered, and genetic approaches (e.g., RNAi) may provide complementary insights. Nevertheless, the mechanistic framework established here is likely transferable to other invertebrate cell models and potentially to studies of related mollicute pathogens.

    Why this cross-domain matters, maturity, and limitations

    Mechanistic parallels between bacterial and viral exploitation of endocytic pathways justify the application of similar chemical biology toolkits across domains. The maturity of endocytosis research in virology (e.g., grass carp reovirus) supports the validity of translating these approaches to bacterial pathogens, though specificity and host-pathogen context must always be empirically validated. Cross-domain insights can accelerate inhibitor screening and the development of intervention strategies, but limitations in cell type, inhibitor selectivity, and physiological relevance remain (Wang et al., 2018).

    Research Support Resources

    Researchers aiming to further dissect endocytic and apoptotic pathways in host-pathogen interactions may benefit from selective chemical tools. For example, the PKC inhibitor Rottlerin (SKU B6803, APExBIO) has been widely used to probe cell proliferation inhibition, apoptosis induction, caspase-3 activation, and PARP cleavage in diverse cell systems (internal dossier). While not employed in the Wei et al. study, Rottlerin is compatible with in vitro cell models for mechanistic studies of endocytosis and cell fate decisions. For optimal results, follow established protocols for DMSO solubilization and storage (source: product_spec). Researchers can review related mechanistic applications in the cancer and virology domains via the referenced internal articles.